Fig. 4From: From one to all: self-assembled theranostic nanoparticles for tumor-targeted imaging and programmed photoactive therapyFluorescence and MSOT imaging assessments of HSCI NPs in vivo. a MSOT imaging at various time-points after intravenous injection of HSCI NPs. b MSOT 3D imaging of tumor at 4 h and 24 h respectively. c Fluorescence imaging at different times of tumor via tail vein injection. d 3D reconstructed transillumination fluorescence imaging of HSCI NPs. e Quantitative fluorescence signal value of tumor at different times. f Fluorescence pictures of the major organs and tumor. g Signal quantitative statistics of major organs and tumor ex vivoBack to article page